Paul R Kirchgraber Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Paul R Kirchgraber.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Paul R Kirchgraber. Paul R Kirchgraber is CEO, Covance Drug Development in LABORATORY CORP OF AMERICA HOLDINGS ($LH).

Latest Insider Trading Transactions of Paul R Kirchgraber

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 10 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...SellS276.552,500691,3757,84410.3 K to 7.8 K (-24.17 %)
Apr 06 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseM0.001,01006,781
Apr 06 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF252.67452114,20710,34410.8 K to 10.3 K (-4.19 %)
Apr 06 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...BuyM0.001,010010,7969.8 K to 10.8 K (+10.32 %)
Mar 30 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF251.58790198,7489,78610.6 K to 9.8 K (-7.47 %)
Mar 30 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...GrantA0.002,104010,5768.5 K to 10.6 K (+24.83 %)
Feb 17 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseM0.0031707,791
Feb 17 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseM0.0026408,108
Feb 17 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF238.269322,1588,4728.6 K to 8.5 K (-1.09 %)
Feb 17 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...BuyM0.0031708,5658.2 K to 8.6 K (+3.84 %)
Feb 17 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF238.268720,7298,2488.3 K to 8.2 K (-1.04 %)
Feb 17 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...BuyM0.0026408,3358.1 K to 8.3 K (+3.27 %)
Feb 08 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseM0.0056008,372
Feb 08 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF223.7818741,8478,0718.3 K to 8.1 K (-2.26 %)
Feb 08 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...BuyM0.0056008,2587.7 K to 8.3 K (+7.27 %)
Feb 04 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseA233.394,6001,073,5944,600
Feb 04 2021LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseA0.001,33008,932
Nov 06 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...SellS214.141,500321,2047,6989.2 K to 7.7 K (-16.31 %)
Nov 04 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseM0.002,00607,602
Nov 04 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF207.23895185,4719,19810.1 K to 9.2 K (-8.87 %)
Nov 04 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...BuyM0.002,00609,1987.2 K to 9.2 K (+27.89 %)
Apr 07 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseM0.001,01009,608
Apr 07 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF113.3137242,1518,0878.5 K to 8.1 K (-4.40 %)
Apr 07 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...BuyM0.001,01008,4597.4 K to 8.5 K (+13.56 %)
Apr 01 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF131.951,014133,7977,4498.5 K to 7.4 K (-11.98 %)
Apr 01 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...GrantA0.003,40208,4635.1 K to 8.5 K (+67.22 %)
Feb 14 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseM0.00316010,618
Feb 14 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseM0.00263010,934
Feb 14 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF187.518816,5015,0615.1 K to 5.1 K (-1.71 %)
Feb 14 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...BuyM0.0031605,1494.8 K to 5.1 K (+6.54 %)
Feb 14 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF187.517113,3134,8334.9 K to 4.8 K (-1.45 %)
Feb 14 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...BuyM0.0026304,9044.6 K to 4.9 K (+5.67 %)
Feb 11 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseM0.00337011,197
Feb 11 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Payment of ExerciseF182.3310318,7804,6414.7 K to 4.6 K (-2.17 %)
Feb 11 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...BuyM0.0033704,7444.4 K to 4.7 K (+7.65 %)
Feb 06 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseA182.517,3001,332,3237,300
Feb 06 2020LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseA0.001,680011,534
Nov 05 2019LHLABORATORY CORP OF ...Kirchgraber Paul RCEO, Covance Drug D ...Option ExerciseA0.006,02009,854

Page:   1

Contact us | Follow us on Twitter